Global Ophthalmic Therapeutic Drugs Market Research Report 2018

世界の眼科用治療薬市場2018

◆タイトル:Global Ophthalmic Therapeutic Drugs Market Research Report 2018
◆商品コード:QYR8054689
◆調査・発行会社:QYResearch
◆発行日:2018年4月
◆ページ数:102
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥310,300見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD5,800 ⇒換算¥620,600見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、世界の眼科用治療薬市場について調査・分析し、眼科用治療薬の世界市場概観、眼科用治療薬の種類別市場分析(抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF剤、その他)、用途別市場分析(病院薬局、オンライン薬局、独立薬局・ドラッグストア)、眼科用治療薬の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・眼科用治療薬の世界市場概観
・眼科用治療薬の種類別市場規模(抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF剤、その他)
・眼科用治療薬の用途別市場規模(病院薬局、オンライン薬局、独立薬局・ドラッグストア)
・眼科用治療薬の世界市場規模
・眼科用治療薬の世界市場規模予測
・眼科用治療薬の主要地域別市場規模
・眼科用治療薬の北米市場規模・予測
・眼科用治療薬のヨーロッパ市場規模・予測
・眼科用治療薬の中国市場規模・予測
・眼科用治療薬の日本市場規模・予測
・眼科用治療薬のアジア市場規模・予測
・眼科用治療薬の製造メーカー分析
・眼科用治療薬のメーカー別生産量
・眼科用治療薬のメーカー別市場シェア
・眼科用治療薬の価格動向・価格分析
・眼科用治療薬の販売(売上高)動向
・眼科用治療薬の貿易(輸出・輸入)動向
・眼科用治療薬の産業チェーン分析
・眼科用治療薬のマーケティング戦略分析
・眼科用治療薬の販売業者(代理店)リスト
・眼科用治療薬の市場環境分析
...

This report studies the global Ophthalmic Therapeutic Drugs market status and forecast, categorizes the global Ophthalmic Therapeutic Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
In 2017, the global Ophthalmic Therapeutic Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Valeant Pharmaceuticals International
Genentech
Regeneron Pharmaceuticals
Shire
Santen Pharmaceutical

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
by Therapeutic Class
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
by Product Type
Prescription Drugs
Over-the-Counter Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

The study objectives of this report are:
To analyze and study the global Ophthalmic Therapeutic Drugs sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Ophthalmic Therapeutic Drugs manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Ophthalmic Therapeutic Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Ophthalmic Therapeutic Drugs Manufacturers
Ophthalmic Therapeutic Drugs Distributors/Traders/Wholesalers
Ophthalmic Therapeutic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Ophthalmic Therapeutic Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Ophthalmic Therapeutic Drugs Market Research Report 2018
1 Ophthalmic Therapeutic Drugs Market Overview
1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs
1.2 Ophthalmic Therapeutic Drugs Segment by Therapeutic Class
1.2.1 Global Ophthalmic Therapeutic Drugs Production and CAGR (%) Comparison by Therapeutic Class (Product Category)(2013-2025)
1.2.2 Global Ophthalmic Therapeutic Drugs Production Market Share by Therapeutic Class (Product Category) in 2017
1.2.3 Anti-inflammatory Drugs
1.2.4 Anti-infective Drugs
1.2.5 Anti-glaucoma Drugs
1.2.6 Anti-allergy Drugs
1.2.7 Anti-VEGF Agents
1.2.8 Others
1.3 Ophthalmic Therapeutic Drugs Segment by Product Type
1.3.1 Prescription Drugs
1.3.2 Over-the-Counter Drugs
1.4 Global Ophthalmic Therapeutic Drugs Segment by Application
1.4.1 Ophthalmic Therapeutic Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.4.2 Hospital Pharmacies
1.4.3 Online Pharmacies
1.4.4 Independent Pharmacies & Drug Stores
1.5 Global Ophthalmic Therapeutic Drugs Market by Region (2013-2025)
1.5.1 Global Ophthalmic Therapeutic Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.5.2 North America Status and Prospect (2013-2025)
1.5.3 Europe Status and Prospect (2013-2025)
1.5.4 Asia-Pacific Status and Prospect (2013-2025)
1.5.5 South America Status and Prospect (2013-2025)
1.5.6 Middle East & Africa Status and Prospect (2013-2025)
1.6 Global Market Size (Value) of Ophthalmic Therapeutic Drugs (2013-2025)
1.6.1 Global Ophthalmic Therapeutic Drugs Revenue Status and Outlook (2013-2025)
1.6.2 Global Ophthalmic Therapeutic Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Ophthalmic Therapeutic Drugs Market Competition by Manufacturers
2.1 Global Ophthalmic Therapeutic Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Ophthalmic Therapeutic Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Ophthalmic Therapeutic Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Ophthalmic Therapeutic Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Ophthalmic Therapeutic Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Ophthalmic Therapeutic Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Ophthalmic Therapeutic Drugs Market Competitive Situation and Trends
2.5.1 Ophthalmic Therapeutic Drugs Market Concentration Rate
2.5.2 Ophthalmic Therapeutic Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Ophthalmic Therapeutic Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Ophthalmic Therapeutic Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Ophthalmic Therapeutic Drugs Production and Market Share by Region (2013-2018)
3.3 Global Ophthalmic Therapeutic Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 Asia-Pacific Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 South America Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Middle East & Africa Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Ophthalmic Therapeutic Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Ophthalmic Therapeutic Drugs Consumption by Region (2013-2018)
4.2 North America Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2013-2018)
4.4 Asia-Pacific Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2013-2018)
4.5 South America Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Middle East & Africa Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2013-2018)

5 Global Ophthalmic Therapeutic Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Ophthalmic Therapeutic Drugs Production and Market Share by Type (2013-2018)
5.2 Global Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Ophthalmic Therapeutic Drugs Price by Type (2013-2018)
5.4 Global Ophthalmic Therapeutic Drugs Production Growth by Type (2013-2018)

6 Global Ophthalmic Therapeutic Drugs Market Analysis by Application
6.1 Global Ophthalmic Therapeutic Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Ophthalmic Therapeutic Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Ophthalmic Therapeutic Drugs Manufacturers Profiles/Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bayer Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Pfizer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Pfizer Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Novartis
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Novartis Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 ALLERGAN
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Aerie Pharmaceuticals
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Valeant Pharmaceuticals International
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Genentech
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Genentech Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Regeneron Pharmaceuticals
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Shire
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Shire Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Santen Pharmaceutical
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview

8 Ophthalmic Therapeutic Drugs Manufacturing Cost Analysis
8.1 Ophthalmic Therapeutic Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Ophthalmic Therapeutic Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Ophthalmic Therapeutic Drugs Market Forecast (2018-2025)
12.1 Global Ophthalmic Therapeutic Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Ophthalmic Therapeutic Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Ophthalmic Therapeutic Drugs Price and Trend Forecast (2018-2025)
12.2 Global Ophthalmic Therapeutic Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 Asia-Pacific Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 South America Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Middle East & Africa Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Ophthalmic Therapeutic Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Ophthalmic Therapeutic Drugs Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Ophthalmic Therapeutic Drugs
Figure Global Ophthalmic Therapeutic Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Ophthalmic Therapeutic Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Anti-inflammatory Drugs
Table Major Manufacturers of Anti-inflammatory Drugs
Figure Product Picture of Anti-infective Drugs
Table Major Manufacturers of Anti-infective Drugs
Figure Product Picture of Anti-glaucoma Drugs
Table Major Manufacturers of Anti-glaucoma Drugs
Figure Product Picture of Anti-allergy Drugs
Table Major Manufacturers of Anti-allergy Drugs
Figure Product Picture of Anti-VEGF Agents
Table Major Manufacturers of Anti-VEGF Agents
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Ophthalmic Therapeutic Drugs Consumption (K Units) by Applications (2013-2025)
Figure Global Ophthalmic Therapeutic Drugs Consumption Market Share by Applications in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Independent Pharmacies & Drug Stores Examples
Table Key Downstream Customer in Independent Pharmacies & Drug Stores
Figure Global Ophthalmic Therapeutic Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure South America Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East & Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Ophthalmic Therapeutic Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Ophthalmic Therapeutic Drugs Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Ophthalmic Therapeutic Drugs Major Players Product Capacity (K Units) (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Ophthalmic Therapeutic Drugs Capacity (K Units) of Key Manufacturers in 2018
Figure Global Ophthalmic Therapeutic Drugs Major Players Product Production (K Units) (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Production (K Units) of Key Manufacturers (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Ophthalmic Therapeutic Drugs Production Share by Manufacturers
Figure 2017 Ophthalmic Therapeutic Drugs Production Share by Manufacturers
Figure Global Ophthalmic Therapeutic Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers
Table 2018 Global Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers
Table Global Market Ophthalmic Therapeutic Drugs Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Ophthalmic Therapeutic Drugs Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Ophthalmic Therapeutic Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Ophthalmic Therapeutic Drugs Product Category
Figure Ophthalmic Therapeutic Drugs Market Share of Top 3 Manufacturers
Figure Ophthalmic Therapeutic Drugs Market Share of Top 5 Manufacturers
Table Global Ophthalmic Therapeutic Drugs Capacity (K Units) by Region (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Capacity Market Share by Region (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Ophthalmic Therapeutic Drugs Capacity Market Share by Region
Table Global Ophthalmic Therapeutic Drugs Production by Region (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Production (K Units) by Region (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Ophthalmic Therapeutic Drugs Production Market Share by Region
Table Global Ophthalmic Therapeutic Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Revenue Market Share by Region (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Region
Figure Global Ophthalmic Therapeutic Drugs Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Asia-Pacific Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table South America Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Middle East & Africa Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Consumption (K Units) Market by Region (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Consumption Market Share by Region (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Ophthalmic Therapeutic Drugs Consumption (K Units) Market Share by Region
Table North America Ophthalmic Therapeutic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Ophthalmic Therapeutic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Asia-Pacific Ophthalmic Therapeutic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table South America Ophthalmic Therapeutic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Middle East & Africa Ophthalmic Therapeutic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Production (K Units) by Type (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Ophthalmic Therapeutic Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Ophthalmic Therapeutic Drugs by Type
Table Global Ophthalmic Therapeutic Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Ophthalmic Therapeutic Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Ophthalmic Therapeutic Drugs by Type
Table Global Ophthalmic Therapeutic Drugs Price (USD/Unit) by Type (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Production Growth by Type (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Consumption (K Units) by Application (2013-2018)
Table Global Ophthalmic Therapeutic Drugs Consumption Market Share by Application (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Consumption Market Share by Application in 2017
Table Global Ophthalmic Therapeutic Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Ophthalmic Therapeutic Drugs Consumption Growth Rate by Application (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Bayer Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Bayer Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Pfizer Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Pfizer Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Novartis Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Novartis Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table ALLERGAN Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALLERGAN Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Aerie Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genentech Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Genentech Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Genentech Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Shire Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Shire Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Santen Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production Growth Rate (2013-2018)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production Market Share (2013-2018)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Therapeutic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs
Figure Ophthalmic Therapeutic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2017
Table Major Buyers of Ophthalmic Therapeutic Drugs
Table Distributors/Traders List
Figure Global Ophthalmic Therapeutic Drugs Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Ophthalmic Therapeutic Drugs Production (K Units) Forecast by Region (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Ophthalmic Therapeutic Drugs Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Ophthalmic Therapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Ophthalmic Therapeutic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Ophthalmic Therapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Ophthalmic Therapeutic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Asia-Pacific Ophthalmic Therapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Ophthalmic Therapeutic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure South America Ophthalmic Therapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure South America Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table South America Ophthalmic Therapeutic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Middle East & Africa Ophthalmic Therapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Middle East & Africa Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Middle East & Africa Ophthalmic Therapeutic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Ophthalmic Therapeutic Drugs Production (K Units) Forecast by Type (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Production (K Units) Forecast by Type (2018-2025)
Table Global Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Ophthalmic Therapeutic Drugs Price Forecast by Type (2018-2025)
Table Global Ophthalmic Therapeutic Drugs Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Ophthalmic Therapeutic Drugs Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


【レポートのキーワード】

眼科用治療薬、抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF剤、病院薬局、オンライン薬局、独立薬局・ドラッグストア

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の眼科用治療薬市場2018] (Global Ophthalmic Therapeutic Drugs Market Research Report 2018 / QYR8054689)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆